Advanced Search
- Cancer
- Chronic Diseases / Disorders
- Community Health Centres
- COVID-19
- Diabetes
- Diagnosis
- Fetal Alcohol Spectrum Disorder (FASD)
- Health Economics / Healthcare Costs
- Health Measurement Tools
- Health Policy
- Health Technology Assessment
- Health Topic Overviews
- Healthcare Services
- Infectious Diseases
- Maternal and Child Health
- Mental Health
- Nurse Practitioners
- Other
- Pharmaceuticals
- Prevention
- Primary Care
- Quality of Life
- Scoping Reviews
- Screening
- Surveillance
- Telehealth
- Therapy
Observations on proposed changes to PMPRB regulations and guidelines: A briefing document for IHE stakeholders
This brief outlines some perspectives from the Institute of Health Economics (IHE) based on what we have heard from government, public agencies, and industry, and seeks to summarize the key areas where further clarification and deliberation could be helpful.
Year of Publication: 2018
Topics: Pharmaceuticals
Authors: Dan Palfrey, John Sproule, Christopher McCabe